BLI Technology for Comprehensive Characterization of Biotherapeutics
In partnership with BioPharm International
Overview
The evolution of regulatory guidelines for biosimilars alongside improvements in knowledge and understanding provide a platform for growth in the industry. Technology to support their rapid growth must simplify and streamline processes during drug development.
Discover expert insights into the BLI technology that's revolutionizing quality control in the biopharmaceutical industry. From regulatory compliance to overcoming development hurdles, this eBook is an essential resource for professionals in the field.
Download the eBook and learn about the following:
- The Evolution of Biosimilars
- Using bio-layer interferometry for quality control
- Using bio-layer interferometry during downstream processing
- Meeting GMP compliance requirements with bio-layer interferometry
This Resource is Designed for:
- Analytical Lab Assistants
- Engineers
- Lab Researchers
- Quality Control Scientists
- Biosimilar Manufacturer
- Pharmaceutical Manufacturers
Applications Supported:
- Biopharmaceutical Quality Control (QC) Testing
- Octet® Bio-Layer Interferometry (BLI) Label-Free Detection Systems
- Kinetic Screening
- Biosimilar Development
- Pharmaceutical Development
- Biomolecular Interactions Analysis
- GMP Compliance
- Rapid Downstream Processing